ArticleFrontiers in cardiovascular medicine2026
Case Report: Pleuro-myopericarditis in a frail older patient in an acute geriatric unit: the evidence gap in guideline-based therapy.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Current ESC guidelines recommend NSAIDs and colchicine as first-line therapy for acute pericarditis. However, supporting evidence is largely derived from younger and clinically stable populations, with frail older patients underrepresented, highlighting a gap between guideline recommendations and real-world applicability. Case presentation: We report the case of an 87-year-old frail man with multiple comorbidities who developed pleuro-myopericarditis with moderate-to-severe pericardial effusion. First-line therapy with ibuprofen and colchicine was initiated but discontinued early due to severe gastrointestinal intolerance and worsening renal function. Pericardiocentesis was considered; however, according to current guideline recommendations, it is primarily indicated in the presence of cardiac tamponade or for selected diagnostic purposes. In this case, the absence of hemodynamic compromise and the high procedural risk related to frailty led to conservative management. A corticosteroid-based regimen was therefore initiated, resulting in clinical improvement and gradual reduction of pericardial effusion. Discussion: This case highlights the limitations of guideline-directed therapy in frail elderly patients, in whom comorbidities, renal dysfunction, and polypharmacy frequently limit the tolerability of NSAIDs and colchicine. It underscores the gap between guideline recommendations and real-world clinical applicability, emphasizing the need for individualized therapeutic strategies. Conclusion: Management of acute pericarditis in frail older adults should be individualized, integrating guideline recommendations with geriatric assessment and clinical judgment. Optimal treatment may differ from guideline-based strategies when patient-specific risks outweigh expected benefits. This case underscores the urgent need for evidence specifically addressing this growing and vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.